• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性膜性肾病患者血清抗磷脂酶 A2 受体抗体与肾小球抗原。

Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.

机构信息

Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214000, China.

Nanjing Medical University, Nanjing 211166, China.

出版信息

Biomed Res Int. 2020 May 8;2020:1693710. doi: 10.1155/2020/1693710. eCollection 2020.

DOI:10.1155/2020/1693710
PMID:32461964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7232673/
Abstract

BACKGROUND

M-type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible for idiopathic membranous nephropathy (IMN). However, serum PLA2R antibody (PLA2R-Ab) can be inaccurate in distinguishing between IMN and secondary membranous nephropathy, while renal PLA2R antigen (PLA2R-Ag) emerges as an ancillary diagnostic. The present study is aimed at examining the associations between PLA2R-Ab in sera and PLA2R-Ag in kidneys in IMN patients.

METHODS

A total of 93 patients with IMN were retrospectively identified. Their serum PLA2R-Ab and renal PLA2R-Ag expression levels were determined, and the clinical correlations between these parameters and clinical features were examined.

RESULTS

The sensitivities of serum PLA2R-Ab and renal PLA2R-Ag for diagnosing IMN were 74.2% and 88.2%, respectively ( < 0.001), with poor consistency. Higher serum PLA2R-Ab levels were correlated to stronger renal PLA2R-Ag expression ( = 0.048). Patients with positive PLA2R-Ab significantly differed from those with negative levels, in terms of proteinuric levels over 24 hours (4.54 3.46 g/day, = 0.015) and serum albumin (23.28 27.95 g/L, = 0.038). Among patients with positive renal PLA2R-Ag, patients with positive PLA2R-Ab had significantly higher 24-hour proteinuria, when compared to patients with negative PLA2R-Ab (4.57 3.08 g/day, = 0.005). Among those with positive PLA2R-Ab in sera, their PLA2R-Ab levels were correlated with the estimated glomerular filtration and serum creatinine.

CONCLUSION

Serum PLA2R-Ab exhibits a closer correlation with proteinuric severity and renal function, when compared to renal PLA2R-Ag.

摘要

背景

M 型磷脂酶 A2 受体(PLA2R)是导致特发性膜性肾病(IMN)的首个自身抗原。然而,血清 PLA2R 抗体(PLA2R-Ab)在区分特发性膜性肾病和继发性膜性肾病方面可能不够准确,而肾 PLA2R 抗原(PLA2R-Ag)则成为辅助诊断。本研究旨在探讨特发性膜性肾病患者血清 PLA2R-Ab 与肾 PLA2R-Ag 之间的相关性。

方法

回顾性分析 93 例特发性膜性肾病患者,检测其血清 PLA2R-Ab 和肾 PLA2R-Ag 表达水平,并分析这些参数与临床特征的相关性。

结果

血清 PLA2R-Ab 和肾 PLA2R-Ag 诊断特发性膜性肾病的灵敏度分别为 74.2%和 88.2%(<0.001),一致性差。血清 PLA2R-Ab 水平越高,肾 PLA2R-Ag 表达越强(=0.048)。PLA2R-Ab 阳性患者与 PLA2R-Ab 阴性患者相比,24 小时蛋白尿(4.54±3.46 vs. 2.82±3.28,=0.015)和血清白蛋白(23.28±27.95 vs. 32.54±3.37,=0.038)水平差异有统计学意义。在肾 PLA2R-Ag 阳性患者中,PLA2R-Ab 阳性患者的 24 小时蛋白尿显著高于 PLA2R-Ab 阴性患者(4.57±3.08 vs. 2.82±3.28,=0.005)。在 PLA2R-Ab 阳性患者中,其 PLA2R-Ab 水平与估算肾小球滤过率和血清肌酐呈正相关。

结论

与肾 PLA2R-Ag 相比,血清 PLA2R-Ab 与蛋白尿严重程度和肾功能的相关性更强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/0d61de19789f/BMRI2020-1693710.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/d862f1b4c9fa/BMRI2020-1693710.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/94133ffff706/BMRI2020-1693710.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/4080be396c45/BMRI2020-1693710.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/0d61de19789f/BMRI2020-1693710.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/d862f1b4c9fa/BMRI2020-1693710.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/94133ffff706/BMRI2020-1693710.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/4080be396c45/BMRI2020-1693710.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d7/7232673/0d61de19789f/BMRI2020-1693710.004.jpg

相似文献

1
Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.特发性膜性肾病患者血清抗磷脂酶 A2 受体抗体与肾小球抗原。
Biomed Res Int. 2020 May 8;2020:1693710. doi: 10.1155/2020/1693710. eCollection 2020.
2
Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.抗磷脂酶 A2 受体抗体的超敏定量作为特发性膜性肾病的诊断和预后指标。
Sci Rep. 2017 Sep 21;7(1):12049. doi: 10.1038/s41598-017-12014-1.
3
Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.中国单中心回顾性研究:磷脂酶 A2 受体相关和血栓素型 1 域包含 7A 相关特发性膜性肾病的临床和组织学特征。
Med Sci Monit. 2018 Jul 22;24:5076-5083. doi: 10.12659/MSM.909815.
4
[Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].肾磷脂酶A2受体及血清抗磷脂酶A2受体抗体在膜性肾病中的诊断价值
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Apr 28;42(4):395-399. doi: 10.11817/j.issn.1672-7347.2017.04.005.
5
Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.日本膜性肾病患者抗磷脂酶A2受体(PLA2R)抗体与肾小球PLA2R表达
PLoS One. 2016 Jun 29;11(6):e0158154. doi: 10.1371/journal.pone.0158154. eCollection 2016.
6
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.肾小球中 M 型磷脂酶 A2 受体的表达增强与原发性膜性肾病患者血清受体抗体相关。
Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.
7
Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.抗磷脂酶 A2 受体(Anti-PLA2R)抗体在特发性膜性肾病诊断和治疗中的作用:中国单中心观察性研究。
Med Sci Monit. 2019 Dec 9;25:9364-9368. doi: 10.12659/MSM.917732.
8
Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.特发性膜性肾病肾小球磷脂酶 A2 受体抗原和血清抗体分类后肾小球 IgG 亚型转换分析。
Dis Markers. 2021 Aug 30;2021:9965343. doi: 10.1155/2021/9965343. eCollection 2021.
9
Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.特发性膜性肾病和非典型膜性肾病患者血清甘露糖结合凝集素、抗磷脂酶 A2 受体抗体与肾脏结局的相关性:一项单中心回顾性队列研究。
Ren Fail. 2022 Dec;44(1):428-433. doi: 10.1080/0886022X.2022.2048016.
10
Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.磷脂酶 A2 受体抗体、24 小时蛋白尿和血清白蛋白作为环磷酰胺治疗特发性膜性肾病疗效的指标。
J Clin Lab Anal. 2020 Sep;34(9):e23368. doi: 10.1002/jcla.23368. Epub 2020 May 24.

引用本文的文献

1
PLA2R1 and HLA-DQA1 SNP in patients with primary membranous nephropathy.原发性膜性肾病患者的PLA2R1和HLA - DQA1单核苷酸多态性
PLoS One. 2025 Aug 22;20(8):e0328234. doi: 10.1371/journal.pone.0328234. eCollection 2025.
2
Association of M-Type Phospholipase A2 Receptor Deposition in Kidney Tissue with Treatment Outcomes in Patients with Idiopathic Membranous Nephropathy.肾组织中M型磷脂酶A2受体沉积与特发性膜性肾病患者治疗结局的相关性
J Inflamm Res. 2023 Dec 22;16:6319-6328. doi: 10.2147/JIR.S427045. eCollection 2023.
3
Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy.

本文引用的文献

1
Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.外显素 1/外显素 2 相关的膜性肾病。
J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6.
2
Anti-phospholipase A2 receptor antibodies in membranous nephropathy.膜性肾病中的抗磷脂酶A2受体抗体
Kidney Res Clin Pract. 2018 Sep;37(3):181-182. doi: 10.23876/j.krcp.2018.37.3.181. Epub 2018 Sep 30.
3
Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis.
特发性膜性肾病基于定量免疫分析法的抗磷脂酶 A2 受体 IgG4 水平及其 IgG4/IgG 比值的临床评估。
Biomed Res Int. 2022 May 13;2022:9127520. doi: 10.1155/2022/9127520. eCollection 2022.
血清抗磷脂酶A2受体自身抗体和肾小球磷脂酶A2受体抗原对诊断特发性膜性肾病的诊断试验准确性:一项更新的荟萃分析
Front Med (Lausanne). 2018 Apr 26;5:101. doi: 10.3389/fmed.2018.00101. eCollection 2018.
4
Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.抗磷脂酶 A2 受体抗体的超敏定量作为特发性膜性肾病的诊断和预后指标。
Sci Rep. 2017 Sep 21;7(1):12049. doi: 10.1038/s41598-017-12014-1.
5
Treatment of membranous nephropathy: time for a paradigm shift.膜性肾病的治疗:范式转变的时刻。
Nat Rev Nephrol. 2017 Sep;13(9):563-579. doi: 10.1038/nrneph.2017.92. Epub 2017 Jul 3.
6
Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study.中国膜性肾病患者血清抗磷脂酶A2受体(PLA2R)抗体与肾小球PLA2R沉积:一项横断面研究。
Medicine (Baltimore). 2017 Jun;96(24):e7218. doi: 10.1097/MD.0000000000007218.
7
A novel Time-resolved Fluoroimmunoassay for the quantitative detection of Antibodies against the Phospholipase A2 Receptor.一种新型时间分辨荧光免疫分析法,用于定量检测抗磷脂酶 A2 受体抗体。
Sci Rep. 2017 Apr 11;7:46096. doi: 10.1038/srep46096.
8
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.通过检测抗PLA2R抗体并结合检测膜性肾病中PLA2R抗原所发现的PLA2R自身免疫的预后价值:一项为期14年的单中心研究
PLoS One. 2017 Mar 3;12(3):e0173201. doi: 10.1371/journal.pone.0173201. eCollection 2017.
9
Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.通过抗磷脂酶A2受体的超灵敏定量检测改善特发性膜性肾病的诊断
J Allergy Clin Immunol. 2017 Jun;139(6):1988-1990.e2. doi: 10.1016/j.jaci.2016.10.020. Epub 2016 Nov 19.
10
Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experience.原发性膜性肾病患者血清抗M型磷脂酶A2受体抗体的患病率:单中心经验
Indian J Nephrol. 2016 Jul-Aug;26(4):257-61. doi: 10.4103/0971-4065.160334.